|
ARL8A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.855000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.952000E-01 |
| Normal-vs-Stage2 |
4.500200E-01 |
| Normal-vs-Stage3 |
3.481500E-02 |
| Normal-vs-Stage4 |
4.747600E-02 |
| Stage1-vs-Stage2 |
2.190600E-01 |
| Stage1-vs-Stage3 |
5.998800E-03 |
| Stage1-vs-Stage4 |
1.479720E-02 |
| Stage2-vs-Stage3 |
4.671800E-01 |
| Stage2-vs-Stage4 |
4.770200E-01 |
| Stage3-vs-Stage4 |
9.882400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.324420E-01 |
| Normal-vs-AfricanAmerican |
3.694300E-02 |
| Normal-vs-Asian |
4.519800E-01 |
| Caucasian-vs-AfricanAmerican |
1.001570E-03 |
| Caucasian-vs-Asian |
1.599610E-01 |
| AfricanAmerican-vs-Asian |
9.389800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.237700E-03 |
| Normal-vs-Female |
1.396200E-02 |
| Male-vs-Female |
2.63330000027651E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.046200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.909400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.418200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.707200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.174600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.019600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.193400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.217200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.228800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.012600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.924150E-02 |
| Normal-vs-Grade 2 |
6.382200E-01 |
| Normal-vs-Grade 3 |
5.432200E-02 |
| Normal-vs-Grade 4 |
5.281900E-02 |
| Grade 1-vs-Grade 2 |
1.563510E-02 |
| Grade 1-vs-Grade 3 |
7.368800E-04 |
| Grade 1-vs-Grade 4 |
9.811900E-04 |
| Grade 2-vs-Grade 3 |
1.211750E-02 |
| Grade 2-vs-Grade 4 |
1.977830E-02 |
| Grade 3-vs-Grade 4 |
5.778600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.129640E-01 |
| Normal-vs-ccB subtype |
1.003220E-03 |
| ccA subtype-vs-ccB subtype |
4.41319999988643E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.804430E-01 |
| Normal-vs-N1 |
6.937400E-01 |
| N0-vs-N1 |
4.700000E-01 |
|
|
